Clover Health Investments, Corp. (CLOV) vs Maravai LifeSciences Holdings, Inc. (MRVI)

A side-by-side comparison of Clover Health Investments, Corp. and Maravai LifeSciences Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CLOV vs MRVI

growth of $100 · dividends reinvested · last 6y
CLOV -52.6% (-11.7%/yr)MRVI -71.5% (-18.9%/yr)CLOV compounded faster over this window
050100150200Start $100202120222023202420252026$47$29
CLOV MRVI

CLOV vs MRVI: by the numbers

  • •CLOV is the larger company ($2.40B vs $2.28B market cap).
  • •Both run net losses; CLOV's is the smaller (-0.74% vs -37.07% net margin).
  • •CLOV grew revenue faster over the past five years (21.18% vs -17.68% CAGR).

Metrics side by side

Valuation

MetricCLOVMRVI
Forward P/E82.71N/A
P/S ratio0.9710.92
P/B ratio6.3811.14
EV / EBITDAN/A15.76
FCF yield3.09%N/A

Profitability

MetricCLOVMRVI
Gross margin18.57%17.98%
Operating margin-0.74%-3.63%
Net margin-0.74%-37.07%
ROE-4.88%-37.82%
ROIC-4.62%16.96%

Growth (annualized)

MetricCLOVMRVI
Revenue CAGR (5Y)21.18%-17.68%
Total return CAGR (5Y)-8.36%-27.63%

Frequently asked

Which has grown faster, CLOV or MRVI?
Over the past five years, CLOV grew revenue faster — CLOV at a 21.18% CAGR versus MRVI at -17.68%.
How have CLOV and MRVI total returns compared?
Over the past 5 years, CLOV delivered -8.36% and MRVI delivered -27.63% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.